TumFlow:一种用于预测新抗癌分子的AI模型
Davide Rigoni1, Sachithra Yaddehige2, Nicoletta Bianchi3
1Molecular Modelling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Francesco Marzolo 5, 35131 Padova, Italy.
International journal of molecular sciences
|June 19, 2024
概括
人工智能 (AI) 加快了对黑色素瘤的药物发现. 一个新的人工智能模型TumFlow产生了新的,合成可行的抗癌分子,提高了疗效并优化了现有的治疗方法.
科学领域:
- 在瘤学瘤学.
- 计算化学计算化学
- 人工智能在药物发现中的作用
背景情况:
- 黑色素瘤是一种常见的癌症,传统药物发现是缓慢而昂贵的.
- 人工智能 (AI) 提供了一种解决方案,可以加速识别和评估潜在的候选药物.
- 机器学习,特别是规范化流量模型,显示出产生新型治疗分子的前景.
研究的目的:
- 介绍TumFlow,一种用于生成用于癌症治疗的新分子实体的新型AI模型.
- 利用人工智能加速发现有效的抗癌药物.
- 通过确保合成可行性来解决传统生成模型的局限性.
主要方法:
- 开发和训练TumFlow,这是一个利用规范化流动的AI模型.
- 利用了NCI-60数据集,专注于黑色素瘤SK-MEL-28细胞系.
- 应用TumFlow生成新型分子并优化现有的黑色素瘤候选药物.
主要成果:
- TumFlow成功生成了新型分子,预计对瘤生长有更强的疗效.
- 产生的分子被设计为合成可行的,克服了药物发现的关键挑战.
- 优化已知的黑色素瘤药物产生了新的化合物,预测效率有所提高.
结论:
- TumFlow代表了人工智能驱动的癌症药物发现的重大进步.
- 该模型能够产生合成可行且潜在更有效的分子,这加速了治疗的发展.
- 这种人工智能方法对发现新的,未经记录的黑色素瘤治疗方法充满希望.
更多相关视频
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
3.6K
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
10.2K
相关概念视频
02:43Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K